Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Not yet recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

not_yet_recruiting120%
unknown120%
withdrawn120%
completed240%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruiting

Evaluation of Optic Neuritis Using Synthetic Quantitative MRI

NCT06916182
withdrawnnot_applicable

Advanced MR Techniques for Breast Cancer Detection

NCT04020523
unknownnot_applicable

Prediction for Coma Recovery With Comaweb

NCT03874208
completed

Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?

NCT03469596
completed

Study of Normal Hip and Lumbar Bone Marrow With Dynamic Contrast Enhancement Magnetic Resonance Imaging

NCT02371824

Clinical Trials (5)

Showing 5 of 5 trials
NCT06916182

Evaluation of Optic Neuritis Using Synthetic Quantitative MRI

Not Yet Recruiting
NCT04020523Not Applicable

Advanced MR Techniques for Breast Cancer Detection

Withdrawn
NCT03874208Not Applicable

Prediction for Coma Recovery With Comaweb

Unknown
NCT03469596

Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?

Completed
NCT02371824

Study of Normal Hip and Lumbar Bone Marrow With Dynamic Contrast Enhancement Magnetic Resonance Imaging

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5